Diabetes mellitus and the incidence and mortality of colorectal cancer: A meta-analysis of 24 cohort studies

Colorectal Disease

Volumn 14, Issue 11, 2012, Pages 1307-1312

  Luo, W ^a   Cao, Y ^a   Liao, C ^a   Gao, F ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Diabetes mellitus; Meta analysis

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; DIABETES MELLITUS; EMBASE; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMATIC REVIEW;

COHORT STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; RISK;

EID: 84866719703     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.02875.x     Document Type: Article

References (35)

1. Larsson SC, Orsini N, Wolk A. Diabetes mellitus, risk of colorectal cancer: a meta-analysis. Natl Cancer J Inst 2005; 97: 1679-87.
2. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164-79.
3. Seow A, Yuan JM, Koh WP, Lee HP, Yu MC. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 2006; 98: 135-8.
4. Jemal A, Murray T, Ward E et al. Cancer statistics. CA Cancer J Clin 2005; 55: 10-30.
5. Steenland K, Nowlin S, Palu S. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995; 4: 807-11.
6. Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998; 147: 816-25.
7. Hu FB, Manson JE, Liu S et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-7.
8. Schoen RE, Tangen CM, Kuller LH et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147-54.
9. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001; 84: 417-22.
10. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 2004; 13: 915-9.
11. Limburg PJ, Anderson KE, Johnson TW et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005; 14: 133-7.
12. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
13. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 2005; 28: 1805-7.
14. Smith GD, Egger M, Shipley MJ, Marmot MG. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 1992; 136: 1110-4.
15. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159: 1160-7.
16. Campbell PT, Deka A, Jacobs EJ et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 2010; 139: 1138-46.
17. Ogunleye AA, Ogston SA, Morris AD, Evans JM. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009; 101: 1199-201.
18. Ulcickas Yood M, Oliveria SA, Campbell UB, Koro CE. Incidence of cancer in a population-based cohort of patients with type 2 diabetes. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2009; 3: 12-6.
19. Flood A, Strayer L, Schairer C, Schatzkin A. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Causes and Control 2010; 21: 1277-84.
20. He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer 2010; 103: 120-6.
21. Ragozzino M, Melton LJ III, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982; 35: 13-9.
22. Wideroff L, Gridley G, Mellemkjaer L et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997; 89: 1360-5.
23. Weiderpass E, Gridley G, Nyrén O, Ekbom A, Persson I, Adami HO. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 1997; 89: 660-1.
24. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970; 44: 673-86.
25. Limburg PJ, Vierkant RA, Fredericksen ZS et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 2006; 101: 1872-9.
26. Ren X, Zhang X, Zhang X et al. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China. Public Health 2009; 123: 540-4.
27. Swerdlow AJ, Laing SP, Qiao Z et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 2005; 92: 2070-5.
28. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
29. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 412-8.
30. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004; 127: 1044-50.
31. Shao L, Huang Q, Luo M, Lai M. Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients. Endocr Relat Cancer 2004; 11: 141-8.
32. Palmqvist R, Stattin P, Rinaldi S et al. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden. Int J Cancer 2003; 107: 89-93.
33. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-20S.
34. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31: 925-43.
35. Miller BS, Yee D. Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res 2005; 65: 10123-7.